Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.10 1.15% 96.40 95.90 96.80 98.30 94.20 97.70 258,812 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 931.1 8.2 2.8 34.4 387

Spire Healthcare Group PLC Director/PDMR Shareholding

06/04/2020 4:45pm

UK Regulatory (RNS & others)


Spire Healthcare (LSE:SPI)
Historical Stock Chart


From Mar 2020 to May 2020

Click Here for more Spire Healthcare Charts.

TIDMSPI

RNS Number : 9536I

Spire Healthcare Group PLC

06 April 2020

Spire Healthcare Group plc

6 April 2020

Notification of Transactions of Persons Discharging Managerial Responsibilities

This notification is made in accordance with DTR 3.1.4R (1) (a) of the Disclosure Rules and Transparency Rules.

Grant of Deferred Share Bonus Plan Awards

Spire Healthcare Group plc (the "Company") announces that on 6 April 2020, awards (the DSBP Awards) were granted over the Company's ordinary shares in the form of nil-cost options to the Directors named below, under the Spire Healthcare Group plc Deferred Share Bonus Plan (the "DSBP").

Under the DSBP, Executive Directors are required to defer a proportion of their gross cash bonus into shares in the Company for a period of three years. The Directors listed below have the following interest in shares as deferred share bonus awards under the DSBP:

 
 Director        Percentage deferral   Deferred Shares 
                  of 2019 gross cash 
                  bonus* 
 Justin Ash      50%                   170,833 
 Jitesh Sodha    33%                   73,140 
 

* As disclosed in the 2019 Annual Report and Accounts

The share price used to determine the number of Deferred Shares subject to award was 81.0 pence, the mid-market closing share price over the dealing day on 3 April 2020.

The DSBP Awards will vest on the third anniversary of the grant date on 6 April 2023, subject to the conditions set out in the 2019 Annual Report and Accounts including continued employment. Upon vesting, the options will remain exercisable until 5 April 2030.

Grant of 2020 Long Term Incentive Plan awards

The Company further announces that, on 6 April 2020, a performance share award (the "LTIP Award") was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Directors in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan ("LTIP").

   Director                      Maximum number of shares under Award 
   Justin Ash                   1,028,046 
   Jitesh Sodha               660,289 

The number of shares set out above represents 150% of each Executive Director's base salary and is the maximum number which may vest under the LTIP Awards following the end of the performance period (31 December 2022). The shareholder approved Remuneration Policy permits awards of up to 200% of base salary.

The actual number of shares which vest will depend on the extent to which the relevant performance conditions have been satisfied.

The performance conditions applicable to the LTIP Awards will be based as follows:

   --    40% on relative total shareholder return (TSR) performance; 
   --    20% on adjusted earnings per share (EPS) performance; and 
   --    40% on two Operational Excellence measures. 

Further details of these performance conditions are disclosed on the Company's website and details of the LTIP in the 2019 Directors' Remuneration Report.

The share price used to determine the number of shares under the LTIP Awards was 89.7 pence being the average of the middle market quotation over the 30 trading days ending on 3 April 2020.

The transaction place is London.

Notes:

   1)   The 2020 awards described above will also be subject to a further two-year holding period. 

2) As previously disclosed, Justin Ash and Jitesh Sodha also have interests in awards granted under the Long Term Incentive Plan during 2018 and 2019. Details of these can be found in the Company's 2019 Annual Report and Accounts.

3) The actual number of shares which vest will depend on the extent to which the relevant performance conditions are satisfied in due course.

Name of contact and telephone number for queries:

Philip Davies

Deputy Company Secretary

Spire Healthcare Group plc

   Tel:      07803 508348 

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 
 
 a)    Name                                   Justin Ash 
      -------------------------------------  -------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------- 
 a)    Position/status                        Chief Executive Officer 
      -------------------------------------  -------------------------------------------- 
 b)    Initial notification                   Initial notification 
        /Amendment 
      -------------------------------------  -------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------- 
 a)    Name                                   Spire Healthcare Group plc 
      -------------------------------------  -------------------------------------------- 
 b)    LEI                                    213800IBJPW3SE2RA350 
      -------------------------------------  -------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ----------------------------------------------------------------------------------- 
 a)    Description of                         Ordinary shares of 1 pence each 
        the financial 
        instrument, type                       GB00BNLPYF73 
        of instrument 
        Identification 
        code 
      -------------------------------------  -------------------------------------------- 
 b)    Nature of the                          Grant of performance share awards under 
        transaction                            the Company's Deferred Share Bonus Plan 
      -------------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s)                      Price(s)               Volume(s) 
      -------------------------------------  --------------------  ---------------------- 
                                Nil                                        107,833 
  ---------------------------------------------------------------  ---------------------- 
 
 d)    Aggregated information                 As above 
        - Aggregated volume 
        - Price 
      -------------------------------------  -------------------------------------------- 
 e)    Date of the transaction                2020-04-06 
      -------------------------------------  -------------------------------------------- 
 f)    Place of the transaction               XLON 
      -------------------------------------  -------------------------------------------- 
 
 
 
 a)    Name                                   Jitesh Sodha 
      -------------------------------------  -------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------- 
 a)    Position/status                        Chief Financial Officer 
      -------------------------------------  -------------------------------------------- 
 b)    Initial notification                   Initial notification 
        /Amendment 
      -------------------------------------  -------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------- 
 a)    Name                                   Spire Healthcare Group plc 
      -------------------------------------  -------------------------------------------- 
 b)    LEI                                    213800IBJPW3SE2RA350 
      -------------------------------------  -------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ----------------------------------------------------------------------------------- 
 a)    Description of                         Ordinary shares of 1 pence each 
        the financial 
        instrument, type                       GB00BNLPYF73 
        of instrument 
        Identification 
        code 
      -------------------------------------  -------------------------------------------- 
 b)    Nature of the                          Grant of performance share awards under 
        transaction                            the Company's Deferred Share Bonus Plan 
      -------------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s)                      Price(s)               Volume(s) 
      -------------------------------------  --------------------  ---------------------- 
                                Nil                                        73,140 
  ---------------------------------------------------------------  ---------------------- 
 
 d)    Aggregated information                 As above 
        - Aggregated volume 
        - Price 
      -------------------------------------  -------------------------------------------- 
 e)    Date of the transaction                2020-04-06 
      -------------------------------------  -------------------------------------------- 
 f)    Place of the transaction               XLON 
      -------------------------------------  -------------------------------------------- 
 
 
 
 a)    Name                                   Justin Ash 
      -------------------------------------  ------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------- 
 a)    Position/status                        Chief Executive Officer 
      -------------------------------------  ------------------------------------------- 
 b)    Initial notification                   Initial notification 
        /Amendment 
      -------------------------------------  ------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------------- 
 a)    Name                                   Spire Healthcare Group plc 
      -------------------------------------  ------------------------------------------- 
 b)    LEI                                    213800IBJPW3SE2RA350 
      -------------------------------------  ------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------------------- 
 a)    Description of                         Ordinary shares of 1 pence each 
        the financial 
        instrument, type                       GB00BNLPYF73 
        of instrument 
        Identification 
        code 
      -------------------------------------  ------------------------------------------- 
 b)    Nature of the                          Grant of performance share awards under 
        transaction                            the Company's Long Term Incentive Plan 
      -------------------------------------  ------------------------------------------- 
 c)    Price(s) and volume(s)                      Price(s)              Volume(s) 
      -------------------------------------  --------------------  --------------------- 
                                Nil                                      1,028,046 
  ---------------------------------------------------------------  --------------------- 
 
 d)    Aggregated information                 As above 
        - Aggregated volume 
        - Price 
      -------------------------------------  ------------------------------------------- 
 e)    Date of the transaction                2020-04-06 
      -------------------------------------  ------------------------------------------- 
 f)    Place of the transaction               XLON 
      -------------------------------------  ------------------------------------------- 
 
 
 
 a)    Name                                   Jitesh Sodha 
      -------------------------------------  ------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------- 
 a)    Position/status                        Chief Financial Officer 
      -------------------------------------  ------------------------------------------- 
 b)    Initial notification                   Initial notification 
        /Amendment 
      -------------------------------------  ------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------------- 
 a)    Name                                   Spire Healthcare Group plc 
      -------------------------------------  ------------------------------------------- 
 b)    LEI                                    213800IBJPW3SE2RA350 
      -------------------------------------  ------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------------------- 
 a)    Description of                         Ordinary shares of 1 pence each 
        the financial 
        instrument, type                       GB00BNLPYF73 
        of instrument 
        Identification 
        code 
      -------------------------------------  ------------------------------------------- 
 b)    Nature of the                          Grant of performance share awards under 
        transaction                            the Company's Long Term Incentive Plan 
      -------------------------------------  ------------------------------------------- 
 c)    Price(s) and volume(s)                      Price(s)              Volume(s) 
      -------------------------------------  --------------------  --------------------- 
                                Nil                                       660,289 
  ---------------------------------------------------------------  --------------------- 
 
 d)    Aggregated information                 As above 
        - Aggregated volume 
        - Price 
      -------------------------------------  ------------------------------------------- 
 e)    Date of the transaction                2020-04-06 
      -------------------------------------  ------------------------------------------- 
 f)    Place of the transaction               XLON 
      -------------------------------------  ------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBUGDSXXGDGGL

(END) Dow Jones Newswires

April 06, 2020 11:45 ET (15:45 GMT)

1 Year Spire Healthcare Chart

1 Year Spire Healthcare Chart

1 Month Spire Healthcare Chart

1 Month Spire Healthcare Chart
ADVFN Advertorial
Your Recent History
LSE
SPI
Spire Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200525 15:40:34